Clinical Trial Update: Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Botulinum Type A toxin for treating crow's feet (lateral canthal lines) is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lateral Canthal Lines

Drugs mentioned

• Botulinum Type A toxin

Snippet

Sponsor: Ipsen | Conditions: Lateral Canthal Lines | Phase 2 | Status: COMPLETED